1 Introduction to Research & Analysis Reports
1.1 Oral COVID-19 Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Oral COVID-19 Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Oral COVID-19 Drug Overall Market Size
2.1 Global Oral COVID-19 Drug Market Size: 2022 VS 2029
2.2 Global Oral COVID-19 Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Oral COVID-19 Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Oral COVID-19 Drug Players in Global Market
3.2 Top Global Oral COVID-19 Drug Companies Ranked by Revenue
3.3 Global Oral COVID-19 Drug Revenue by Companies
3.4 Global Oral COVID-19 Drug Sales by Companies
3.5 Global Oral COVID-19 Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Oral COVID-19 Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Oral COVID-19 Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Oral COVID-19 Drug Players in Global Market
3.8.1 List of Global Tier 1 Oral COVID-19 Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Oral COVID-19 Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Oral COVID-19 Drug Market Size Markets, 2022 & 2029
4.1.2 Tablet
4.1.3 Capsule
4.2 By Type – Global Oral COVID-19 Drug Revenue & Forecasts
4.2.1 By Type – Global Oral COVID-19 Drug Revenue, 2018-2023
4.2.2 By Type – Global Oral COVID-19 Drug Revenue, 2024-2029
4.2.3 By Type – Global Oral COVID-19 Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Oral COVID-19 Drug Sales & Forecasts
4.3.1 By Type – Global Oral COVID-19 Drug Sales, 2018-2023
4.3.2 By Type – Global Oral COVID-19 Drug Sales, 2024-2029
4.3.3 By Type – Global Oral COVID-19 Drug Sales Market Share, 2018-2029
4.4 By Type – Global Oral COVID-19 Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Oral COVID-19 Drug Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinics
5.2 By Application – Global Oral COVID-19 Drug Revenue & Forecasts
5.2.1 By Application – Global Oral COVID-19 Drug Revenue, 2018-2023
5.2.2 By Application – Global Oral COVID-19 Drug Revenue, 2024-2029
5.2.3 By Application – Global Oral COVID-19 Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Oral COVID-19 Drug Sales & Forecasts
5.3.1 By Application – Global Oral COVID-19 Drug Sales, 2018-2023
5.3.2 By Application – Global Oral COVID-19 Drug Sales, 2024-2029
5.3.3 By Application – Global Oral COVID-19 Drug Sales Market Share, 2018-2029
5.4 By Application – Global Oral COVID-19 Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Oral COVID-19 Drug Market Size, 2022 & 2029
6.2 By Region – Global Oral COVID-19 Drug Revenue & Forecasts
6.2.1 By Region – Global Oral COVID-19 Drug Revenue, 2018-2023
6.2.2 By Region – Global Oral COVID-19 Drug Revenue, 2024-2029
6.2.3 By Region – Global Oral COVID-19 Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Oral COVID-19 Drug Sales & Forecasts
6.3.1 By Region – Global Oral COVID-19 Drug Sales, 2018-2023
6.3.2 By Region – Global Oral COVID-19 Drug Sales, 2024-2029
6.3.3 By Region – Global Oral COVID-19 Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Oral COVID-19 Drug Revenue, 2018-2029
6.4.2 By Country – North America Oral COVID-19 Drug Sales, 2018-2029
6.4.3 US Oral COVID-19 Drug Market Size, 2018-2029
6.4.4 Canada Oral COVID-19 Drug Market Size, 2018-2029
6.4.5 Mexico Oral COVID-19 Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Oral COVID-19 Drug Revenue, 2018-2029
6.5.2 By Country – Europe Oral COVID-19 Drug Sales, 2018-2029
6.5.3 Germany Oral COVID-19 Drug Market Size, 2018-2029
6.5.4 France Oral COVID-19 Drug Market Size, 2018-2029
6.5.5 U.K. Oral COVID-19 Drug Market Size, 2018-2029
6.5.6 Italy Oral COVID-19 Drug Market Size, 2018-2029
6.5.7 Russia Oral COVID-19 Drug Market Size, 2018-2029
6.5.8 Nordic Countries Oral COVID-19 Drug Market Size, 2018-2029
6.5.9 Benelux Oral COVID-19 Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Oral COVID-19 Drug Revenue, 2018-2029
6.6.2 By Region – Asia Oral COVID-19 Drug Sales, 2018-2029
6.6.3 China Oral COVID-19 Drug Market Size, 2018-2029
6.6.4 Japan Oral COVID-19 Drug Market Size, 2018-2029
6.6.5 South Korea Oral COVID-19 Drug Market Size, 2018-2029
6.6.6 Southeast Asia Oral COVID-19 Drug Market Size, 2018-2029
6.6.7 India Oral COVID-19 Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Oral COVID-19 Drug Revenue, 2018-2029
6.7.2 By Country – South America Oral COVID-19 Drug Sales, 2018-2029
6.7.3 Brazil Oral COVID-19 Drug Market Size, 2018-2029
6.7.4 Argentina Oral COVID-19 Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Oral COVID-19 Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Oral COVID-19 Drug Sales, 2018-2029
6.8.3 Turkey Oral COVID-19 Drug Market Size, 2018-2029
6.8.4 Israel Oral COVID-19 Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Oral COVID-19 Drug Market Size, 2018-2029
6.8.6 UAE Oral COVID-19 Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Pfizer
7.1.1 Pfizer Company Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer Oral COVID-19 Drug Major Product Offerings
7.1.4 Pfizer Oral COVID-19 Drug Sales and Revenue in Global (2018-2023)
7.1.5 Pfizer Key News & Latest Developments
7.2 MSD and Ridgeback
7.2.1 MSD and Ridgeback Company Summary
7.2.2 MSD and Ridgeback Business Overview
7.2.3 MSD and Ridgeback Oral COVID-19 Drug Major Product Offerings
7.2.4 MSD and Ridgeback Oral COVID-19 Drug Sales and Revenue in Global (2018-2023)
7.2.5 MSD and Ridgeback Key News & Latest Developments
7.3 Shionogi
7.3.1 Shionogi Company Summary
7.3.2 Shionogi Business Overview
7.3.3 Shionogi Oral COVID-19 Drug Major Product Offerings
7.3.4 Shionogi Oral COVID-19 Drug Sales and Revenue in Global (2018-2023)
7.3.5 Shionogi Key News & Latest Developments
8 Global Oral COVID-19 Drug Production Capacity, Analysis
8.1 Global Oral COVID-19 Drug Production Capacity, 2018-2029
8.2 Oral COVID-19 Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Oral COVID-19 Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Oral COVID-19 Drug Supply Chain Analysis
10.1 Oral COVID-19 Drug Industry Value Chain
10.2 Oral COVID-19 Drug Upstream Market
10.3 Oral COVID-19 Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Oral COVID-19 Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界の経口新型コロナウイルス感染症治療薬市場予測2023-2029：錠剤、カプセル |
| 【英語タイトル】Oral COVID-19 Drug Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5840 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：79 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医薬品＆医療 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界の経口新型コロナウイルス感染症治療薬市場規模と予測を収録しています。・世界の経口新型コロナウイルス感染症治療薬市場：売上、2018年-2023年、2024年-2029年 ・世界の経口新型コロナウイルス感染症治療薬市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の経口新型コロナウイルス感染症治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「錠剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 経口新型コロナウイルス感染症治療薬のグローバル主要企業は、Pfizer、 MSD and Ridgeback、 Shionogiなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、経口新型コロナウイルス感染症治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の経口新型コロナウイルス感染症治療薬市場：タイプ別、2018年-2023年、2024年-2029年 世界の経口新型コロナウイルス感染症治療薬市場：タイプ別市場シェア、2022年 ・錠剤、カプセル 世界の経口新型コロナウイルス感染症治療薬市場：用途別、2018年-2023年、2024年-2029年 世界の経口新型コロナウイルス感染症治療薬市場：用途別市場シェア、2022年 ・病院、診療所 世界の経口新型コロナウイルス感染症治療薬市場：地域・国別、2018年-2023年、2024年-2029年 世界の経口新型コロナウイルス感染症治療薬市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における経口新型コロナウイルス感染症治療薬のグローバル売上、2018年-2023年 ・主要企業における経口新型コロナウイルス感染症治療薬のグローバル売上シェア、2022年 ・主要企業における経口新型コロナウイルス感染症治療薬のグローバル販売量、2018年-2023年 ・主要企業における経口新型コロナウイルス感染症治療薬のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Pfizer、 MSD and Ridgeback、 Shionogi ************************************************************* ・調査・分析レポートの概要 経口新型コロナウイルス感染症治療薬市場の定義 市場セグメント 世界の経口新型コロナウイルス感染症治療薬市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の経口新型コロナウイルス感染症治療薬市場規模 世界の経口新型コロナウイルス感染症治療薬市場規模：2022年 VS 2029年 世界の経口新型コロナウイルス感染症治療薬市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの経口新型コロナウイルス感染症治療薬の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の経口新型コロナウイルス感染症治療薬製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：錠剤、カプセル 経口新型コロナウイルス感染症治療薬のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所 経口新型コロナウイルス感染症治療薬の用途別グローバル売上・予測 ・地域別市場分析 地域別経口新型コロナウイルス感染症治療薬市場規模 2022年と2029年 地域別経口新型コロナウイルス感染症治療薬売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Pfizer、 MSD and Ridgeback、 Shionogi ... |
This report aims to provide a comprehensive presentation of the global market for Oral COVID-19 Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral COVID-19 Drug. This report contains market size and forecasts of Oral COVID-19 Drug in global, including the following market information:
Global Oral COVID-19 Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Oral COVID-19 Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Oral COVID-19 Drug companies in 2022 (%)
The global Oral COVID-19 Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Oral COVID-19 Drug include Pfizer, MSD and Ridgeback and Shionogi, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oral COVID-19 Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oral COVID-19 Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oral COVID-19 Drug Market Segment Percentages, by Type, 2022 (%)
Tablet
Capsule
Global Oral COVID-19 Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oral COVID-19 Drug Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinics
Global Oral COVID-19 Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Oral COVID-19 Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oral COVID-19 Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Oral COVID-19 Drug revenues share in global market, 2022 (%)
Key companies Oral COVID-19 Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Oral COVID-19 Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
MSD and Ridgeback
Shionogi
Outline of Major Chapters:
Chapter 1: Introduces the definition of Oral COVID-19 Drug, market overview.
Chapter 2: Global Oral COVID-19 Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Oral COVID-19 Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Oral COVID-19 Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Oral COVID-19 Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界の経口新型コロナウイルス感染症治療薬市場予測2023-2029：錠剤、カプセル] (コード：MMG23JU5840)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の経口新型コロナウイルス感染症治療薬市場予測2023-2029：錠剤、カプセル]についてメールでお問い合わせ |
